These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3025583)

  • 1. Neuropeptides and seizures.
    Snead OC
    Neurol Clin; 1986 Nov; 4(4):863-75. PubMed ID: 3025583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptides: anticonvulsant and convulsant mechanisms in epileptic model systems and in humans.
    Bajorek JG; Lee RJ; Lomax P
    Adv Neurol; 1986; 44():489-500. PubMed ID: 2871723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interictal behavioral disturbances: a search for molecular substrates.
    Engel J; Rocha LL
    Epilepsy Res Suppl; 1992; 9():341-9; discussion 350. PubMed ID: 1337448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptides: a role as endogenous mediators or modulators of epileptic phenomena.
    Bajorek JG; Lee RJ; Lomax P
    Ann Neurol; 1984; 16 Suppl():S31-8. PubMed ID: 6095740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptides and seizures: an experimental model on the possible relationship among C.R.F., ACTH and endorphinic system.
    Ortolani E; De Maria G; Di Giannuario A; Loizzo A; Nerozzi D
    Adv Biochem Psychopharmacol; 1987; 43():329-34. PubMed ID: 3035893
    [No Abstract]   [Full Text] [Related]  

  • 6. ACTH-related peptides, kindling and seizure disorders.
    Goldman H; Berman RF; Murphy S
    Adv Biochem Psychopharmacol; 1987; 43():317-27. PubMed ID: 3035892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone in endotoxic shock: experimental models and clinical perspective.
    Gurll N
    Adv Shock Res; 1983; 10():63-71. PubMed ID: 6308974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tramadol, a centrally acting opioid: anticonvulsant effect against maximal electroshock seizure in mice.
    Manocha A; Sharma KK; Mediratta PK
    Indian J Physiol Pharmacol; 1998 Jul; 42(3):407-11. PubMed ID: 9741657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant actions of deoxycorticosterone.
    Perez-Cruz C; Lonsdale D; Burnham WM
    Brain Res; 2007 May; 1145():81-9. PubMed ID: 17368435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC; Robles L; Mosberg HI
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of ACTH and adrenocorticosteroids on seizure susceptibility in 15-day-old male rats.
    Edwards HE; Vimal S; Burnham WM
    Exp Neurol; 2002 May; 175(1):182-90. PubMed ID: 12009770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiate receptor mediated effects of IFN-alpha and lymphocyte derived endorphin-like peptides.
    Smith EM; Dion LD; Blalock JE
    Prog Clin Biol Res; 1985; 192():259-64. PubMed ID: 3001757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The delta opioid receptor agonist, SNC80, has complex, dose-dependent effects on pilocarpine-induced seizures in Sprague-Dawley rats.
    Bausch SB; Garland JP; Yamada J
    Brain Res; 2005 May; 1045(1-2):38-44. PubMed ID: 15910761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of opioid peptide metabolism by seizures: differentiation of opioid subclasses.
    McGinty JF; Kanamatsu T; Obie J; Hong JS
    NIDA Res Monogr; 1986; 71():89-101. PubMed ID: 3025738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral endorphin: can in vitro experiments explain in vivo results?
    Sarne Y; Gothilf Y; Weissman BA
    Prog Biochem Pharmacol; 1980; 16():41-8. PubMed ID: 6255489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ontogeny of seizures induced by leucine-enkephalin and beta-endorphin.
    Snead OC; Stephens H
    Ann Neurol; 1984 Jun; 15(6):594-8. PubMed ID: 6331281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsy.
    Löscher W; Dekundy A; Nagel J; Danysz W; Parsons CG; Potschka H
    Neuropharmacology; 2006 Jun; 50(8):1006-15. PubMed ID: 16563443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. II. The novel imidazoquinazolines NNC 14-0185 and NNC 14-0189.
    Löscher W; Rundfeldt C; Hönack D; Ebert U
    J Pharmacol Exp Ther; 1996 Nov; 279(2):573-81. PubMed ID: 8930159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epileptic and anticonvulsant properties of opioid peptides.
    Cannon JT; Caldecott-Hazard S; Shavit Y; Lewis JW; Liebeskind JC
    Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():30-5. PubMed ID: 6962026
    [No Abstract]   [Full Text] [Related]  

  • 20. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ
    Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.